Moore Aleisha M
Department of Biological Sciences, Brain Health Research Institute, Kent State University, Kent, Ohio, USA.
J Neuroendocrinol. 2025 Apr 18:e70028. doi: 10.1111/jne.70028.
Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility in premenopausal individuals with ovaries worldwide. Despite the diagnostic features of anovulation, ovarian cysts, and hyperandrogenemia, which indicate that ovary dysfunction is the cause of the syndrome, changes in central neuroendocrine circuits are a significant cause of PCOS pathology. Specifically, cells in the hypothalamus have a diminished ability to transmit negative feedback signals from gonadal sex steroid hormones to gonadotropin-releasing hormone (GnRH) neurons. This results in an elevated frequency of pulsatile hypothalamic GnRH and pituitary luteinizing hormone (LH) secretion, leading to ovarian hyperandrogenism and ovulatory dysfunction. In recent years, preclinical research in animal models has rapidly advanced our understanding of the neural mechanisms underlying GnRH pulse generation with the identification of KNDy cells-a unique cell population in the hypothalamus expressing the neuropeptides kisspeptin, neurokinin B and dynorphin. As a result, therapeutics targeting KNDy cell signaling have emerged as a promising avenue for treating GnRH/LH hypersecretion in PCOS patients. However, the precise central changes underpinning impaired negative feedback regulation of GnRH pulse generation in PCOS patients are still unclear. Evidence from both the clinic and animal models suggests that changes in the regulation of KNDy cells may be directly responsible for elevated GnRH and LH pulse frequency in PCOS. However, other cell populations regulating GnRH secretion may also be involved. This review provides an overview of our current understanding of the aetiology and contribution of neuroendocrine dysfunction in PCOS pathology. It also examines the evidence for neural mechanisms underlying GnRH/LH hypersecretion, which may serve as central targets in developing novel treatments. Finally, this review highlights key knowledge gaps that are hindering the development of preventive and curative interventions.
多囊卵巢综合征(PCOS)是全球范围内绝经前有卵巢的个体无排卵性不孕的主要原因。尽管存在无排卵、卵巢囊肿和高雄激素血症等诊断特征,表明卵巢功能障碍是该综合征的病因,但中枢神经内分泌回路的变化是PCOS病理的重要原因。具体而言,下丘脑细胞将性腺性甾体激素的负反馈信号传递给促性腺激素释放激素(GnRH)神经元的能力减弱。这导致下丘脑GnRH脉冲频率和垂体促黄体生成素(LH)分泌增加,进而导致卵巢高雄激素血症和排卵功能障碍。近年来,动物模型的临床前研究通过鉴定KNDy细胞(下丘脑表达神经肽 kisspeptin、神经激肽B和强啡肽的独特细胞群),迅速推进了我们对GnRH脉冲产生的神经机制的理解。因此,针对KNDy细胞信号传导的疗法已成为治疗PCOS患者GnRH/LH分泌过多的有前景的途径。然而,PCOS患者GnRH脉冲产生的负反馈调节受损的精确中枢变化仍不清楚。临床和动物模型的证据表明,KNDy细胞调节的变化可能直接导致PCOS患者GnRH和LH脉冲频率升高。然而,其他调节GnRH分泌的细胞群也可能参与其中。本综述概述了我们目前对PCOS病理中神经内分泌功能障碍的病因和作用的理解。它还研究了GnRH/LH分泌过多的神经机制的证据,这些机制可能作为开发新疗法的核心靶点。最后,本综述强调了阻碍预防和治疗干预发展的关键知识空白。